SNO |
CODE |
Test Parameter |
Sample |
Methodology |
Schedule |
Reporting |
MRP |
1 |
ANEMIA PANEL |
FERRITIN + FOLATE SERUM(FOLIC ACID)+ IRON + TOTAL IRON BINDING CAPACITY (TIBC)+ TRANFERRIN SATURATION+VITMIN-B12 + COMPLETE BLOOD COUNT (CBC)+ PERIPHERAL BLOOD FILM(PBF) |
SERUM/EDTA |
CLIA/ Electrical impedence/Microscopy |
DAILY |
SAME DAY |
1500 |
2 |
ARTHRITIS PANEL |
CALCIUM-TOTAL+ C-REACTIVE PROTEIN(CRP- QUNTITATIVE) + RHEUMATOID FACTOR QUANTATIVE (RA FACTOR) + URIC ACID + COMPLETE BLOOD COUNT (CBC )+ ERYTHROCYTE SEDIMENTATION RATE (ESR)+VITAMIN D3 |
SERUM/EDTA |
Photometry / Electrical impedence/CLIA |
DAILY |
SAME DAY |
1700 |
3 |
CAM-1 |
KIDNEY FUNCTION TEST(RFT+CAL),LIVER FUNCTION TEST (LFT + GGT),LIPID PROFILE,THYROID STIMULATING HORMONE (TSH) + IRON PROFILE |
SERUM |
CLIA/ Photometry |
DAILY |
SAME DAY |
800 |
4 |
CAM-2 |
KIDNEY FUNCTION TEST(RFT+CAL)+LIVER FUNCTION TEST (LFT +GGT)+ LIPID PROFILE+THYROID FUNCTION TEST(T3T4TSH)+IRON PROFILE |
SERUM |
CLIA/ Photometry |
DAILY |
SAME DAY |
1000 |
5 |
CAM-3 |
KIDNEY FUNCTION TEST(RFT+CAL)+LIVER FUNCTION TEST (LFT+GGT)+LIPID PROFILE+THYROID FUNCTION TEST(T3 T4 TSH)+COMPLETE BLOOD COUNT(CBC+ESR)+HbA1C+IRON PROFILE |
SERUM/ EDTA-WB |
CLIA/HPLC/ Electrical impedence/Photometry |
DAILY |
SAME DAY |
1200 |
6 |
CAM-4 |
KIDNEY FUNCTION TEST(SERFT)+LIVER FUNCTION TEST (LFT+GGT)+LIPID PROFILE+THYROID FUNCTION TEST(T3T4TSH)+COMPLETE BLOOD COUNT(CBC+ESR)+HbA1C+ VITAMIN D3+VITAMIN B12+FOLIC ACID +IRON+ URINE R/E |
SERUM/ EDTA-WB |
CLIA/HPLC/ Electrical impedence/Photometry/Microscopy |
DAILY |
SAME DAY |
2000 |
7 |
DIABETIC PROFILE |
BLOOD UREA NITROGEN(BUN) + CHOLESTROL-HDL+CHOLESTROL-LDL +CHOLESTROL-TOTAL + SERUM CREATININE +TRIGLYCERRIDE (TG) + URIC ACID + VLDL-VERY LOW DENSITY LIPPPROTEIN + COMPLETE URINE EXAMINATION(CUE) + SPOT MICROALBUMIN + HbA1c +TSH |
WB-EDTA, SERUM, URINE |
CLIA/Photometry/Turbimetry/Microscopy |
DAILY |
SAME DAY |
1200 |
8 |
|
ELECTROLYTES (Na+, K+, Cl+) |
SERUM |
ISE DIRECT |
DAILY |
SAME DAY |
300 |
9 |
FERTILITY PROFILE-1 |
ANTI MULLARIAN HORMONE(AMH)+FOLLICLE STIMULATING HORMONE (FSH)+PROLACTIN (PRL) +LEUTINISING HORMONE (LH) +THYROID STIMULATING HORMONE (TSH) + ESTRADIOL(E2) |
SERUM |
CLIA/ ELISA |
DAILY |
SAME DAY |
2700 |
10 |
FERTILITY PROFILE-2 |
FOLLICLE STIMULATING HORMONE (FSH) + LUTEINSING(LH) + PROLACTIN |
SERUM |
CLIA |
DAILY |
SAME DAY |
1000 |
11 |
FERTILITY PROFILE-3 |
FOLLICLE STIMULATING HORMONE (FSH) + LUTEINSING(LH) + PROLACTIN +TESTOSTERONE-TOTAL |
SERUM |
CLIA |
DAILY |
SAME DAY |
1500 |
12 |
FERTILITY PROFILE-4 |
FOLLICLE STIMULATING HORMONE (FSH) + LUTEINSING (LH) + PROLACTIN(PRL) + THYROID STIMULATING HORMONE (TSH) |
SERUM |
CLIA |
DAILY |
SAME DAY |
1100 |
13 |
IRON PROFILE |
IRON +TOTAL IRON BINDING CAPACITY-IRON (TIBC)+ %TRANFERRIN SATURATION |
SERUM |
Photometry |
DAILY |
SAME DAY |
800 |
14 |
IRON PROFILE 2 |
IRON +FERRITIN+TOTAL IRON BINDING CAPACITY-IRON (TIBC)+ %TRANFERRIN SATURATION |
SERUM |
Photometry/CLIA |
DAILY |
SAME DAY |
1200 |
15 |
THROID ANTIBODY PANEL |
ANTI THYROGLOULIN (ATG) + ANTI THYROID PEROXIDASE (ANTI-TPO) |
SERUM |
CLIA |
DAILY |
SAME DAY |
1200 |
16 |
THYRIOD-1 |
TOTAL TRIIODOTHYRONINE (T3)+TOTAL THYROXINE (T4)+THYROID STIMULATING HORMONE (TSH) |
SERUM |
CLIA |
DAILY |
SAME DAY |
450 |
17 |
THYRIOD-2 |
TRI-IODOTHYRONINE FREE (FT3) + THYROXINE-FREE (FT4) +THYROID STIMULATING HORMONE (TSH) |
SERUM |
CLIA |
DAILY |
SAME DAY |
550 |
18 |
THYRIOD-3 |
TRI-IODOTHYRONINE FREE (FT3) + THYROXINE-FREE (FT4) THYROID STIMULATING HORMONE(TSH) + THYROXINE-TOTAL(T4) + TRI-IODOTHYRONINE TOTAL(T3) |
SERUM |
CLIA |
DAILY |
SAME DAY |
800 |
19 |
VIRAL MARKER-1 |
HEPATITIS B SURFACE ANTIGEN (HBsAg) +HEPATITIS C VIRUS (HCV) +HUMAN IMMUNODEFICIENCY VIRUS (HIV) |
SERUM |
ELISA |
DAILY |
SECOND DAY |
1500 |
20 |
VIRAL MARKER-2 |
HEPATITIS B SURFACE ANTIGEN (HBsAg) +HEPATITIS C VIRUS (HCV) (ELISA) |
SERUM |
ELISA |
DAILY |
SECOND DAY |
1100 |
21 |
VITAMIN PROFILE |
VIT D3 + VIT B12 + Calcium |
SERUM |
ELISA/Photometry |
DAILY |
SAME DAY |
1200 |
22 |
THALASSEMIA PROFILE |
FERRITIN + IRON +TOTAL IRON BINDING CAPACITY-IRON (TIBC)+ %TRANFERRIN SATURATION + COMPLETE BOOD COUNT (CBC) + HAMOGLOBIN VARIANT ANALYSIS (HPLC)/HB ELECTROPHOSIS |
SERUM/ EDTA-WB |
CLIA/ Electrical impedence/HPCL |
DAILY |
THIRD DAY |
2000 |
23 |
TORCH 10 |
TORCH PANAL-10 (IgG & IgM |
SERUM |
ELISA |
DAILY |
SECOND DAY |
2000 |
24 |
TORCH IgG |
TORCH-5 IgG |
SERUM |
ELISA |
DAILY |
SECOND DAY |
1100 |
25 |
TORCH IgM |
TORCH-5 IgM |
SERUM |
ELISA |
DAILY |
SECOND DAY |
1100 |
26 |
TRIPLE SCREEN |
AFP(Alpha Feto Protein) + BETA- HCG + uE3 (WITH GRAPH) |
SERUM |
ELISA |
DAILY |
THIRD DAY |
1600 |
27 |
DUAL MARKER |
FREE BETA HCG + PAPPa (Pregnancy Associated Plasma Protein ) (WITH GRAPH) |
SERUM |
ELISA |
DAILY |
THIRD DAY |
2000 |
28 |
PROSTATIC PROFILE |
FREE PSA/TOTAL PSA RATIO + PROSTATE SPECIFIC ANTIGEN-PSA(free) + PROSTATE SPECIFIC ANTIGEN -PSA (TOTAL) + PROSTATIC ACID PHOSPHATASE (PAP) |
SERUM |
CLIA/ELISA |
DAILY |
THIRD DAY |
1700 |
29 |
POLYCYSTIC OVARIAN DISEASE (PCOD) PANEL |
DEHYDROEPIANDROSTERONE SULPHATE (DHEA-S) + ESTRADIOL (E2) + FOLLICLE STIMULATING HORMONE (FSH) + INSULIN-FASTING + LUTEINISING HORMOME (LH) + PROLACTIN +TESTOSTERONE-FREE +TESTOSTERONE-TOTAL + THYROID STIMULATING HORMONE (TSH) |
SERUM |
CLIA |
DAILY |
SECOND DAY |
4000 |
30 |
BAD OBSTEIC HISTORY (BOH) PANEL |
LUPUS ANTICOAGULANT (SCREEN) + ANTI NUCLEAR ANTIBODY (ANA) + ANTI PHOSPHOLIPID IgG ANTIBODY + ANTI PHOSPHOLIPID IgM ANTIBODY+ CARDIOLIPIN IgG ANTIBODY + CARDIOLIPIN IgM ANTIBODY + CYTOMEGALOVIRUS IgG ANTIBODY + HERPES SIMPLEX VIRUS 1 & 2 IgG + HERPES SIMPLEX VIRUS 1 & 2 IgM + RUBELLA VIRUS IgG ANTIBODY + RUBELLA VIRUS IgM ANTIBODY + THYROID STIMULATING HORMONE (TSH) + TOXOPLASMA GONDII IgG ANTIBOD + TOXOPLASMA GONDII IgM ANTIBODY |
SERUM/ SODIUM CITRATE |
CLIA/ ELISA |
DAILY |
SECOND DAY |
5500 |
31 |
PREVENTIVE CANCER CHECK-UP (FEMALE ) |
AFP(Alpha Feto Protein) , CA15.3-BREAST CANCER MARKER + CA 19.9- PANCREATIC CANCER MARKER + CARCINO EMBRYOTIC ANTIGEN (CEA) |
SERUM |
CLIA/ ELISA |
DAILY |
THIRD DAY |
3400 |
32 |
PREVENTIVE CANCER CHECK UP (MALE ) |
AFP(Alpha Feto Protein) +CARCINO EMBRYOTIC ANTIGEN (CEA)+ PROSTATE SPECIFIC ANTIGEN-PSA + PROSTATE SPECIFIC ANTIGEN -PSA (TOTAL)+CA 19.9- PANCREATIC CANCER MARKER |
SERUM |
CLIA/ ELISA |
DAILY |
THIRD DAY |
3000 |